{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:27:23Z","timestamp":1772954843420,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T00:00:00Z","timestamp":1396483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.03.061","type":"journal-article","created":{"date-parts":[[2014,3,30]],"date-time":"2014-03-30T00:00:18Z","timestamp":1396137618000},"page":"3307-3315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Intranasally administered Endocine\u2122 formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets"],"prefix":"10.1016","volume":"32","author":[{"given":"Anna-Karin","family":"Maltais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koert J.","family":"Stittelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin J.B.","family":"Veldhuis Kroeze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel L.","family":"Dijkshoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel P.","family":"Krestin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Hinkula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Arwidsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alf","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.03.061_bib0005","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.324_996","article-title":"Swine flu outbreak. Past pandemics provide mixed clues to H1N1's next moves","volume":"324","author":"Cohen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0010","unstructured":"Vaccines against influenza WHO position paper\u2014November 2012. Wkly Epidemiol Rec 2012;87:461\u2013476."},{"key":"10.1016\/j.vaccine.2014.03.061_bib0015","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1016\/j.vaccine.2013.09.063","article-title":"Cochrane re-arranged: support for policies to vaccinate elderly people against influenza","volume":"31","author":"Beyer","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0020","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/255745a0","article-title":"Immune exclusion is a function of IgA","volume":"255","author":"Stokes","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0030","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/eji.1830140414","article-title":"Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity","volume":"14","author":"Liew","year":"1984","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0035","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens","volume":"183","author":"Belyakov","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0040","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2014.03.061_bib0045","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.vaccine.2011.04.119","article-title":"A pandemic influenza vaccine in India: from strain to sale within 12 months","volume":"29","author":"Dhere","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virusres.2011.09.022","article-title":"Immune responses to influenza virus infection","volume":"162","author":"Kreijtz","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10611860701637966","article-title":"Rational design of nasal vaccines","volume":"16","author":"Slutter","year":"2008","journal-title":"J Drug Target"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0060","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0264-410X(02)00155-X","article-title":"A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants","volume":"20","author":"Fujihashi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0065","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0070","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.vaccine.2011.01.009","article-title":"A new intranasal influenza vaccine based on a novel polycationic lipid-ceramide carbamoyl-spermine (CCS) II. Studies in mice and ferrets and mechanism of adjuvanticity","volume":"29","author":"Even-Or","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/CVI.00035-11","article-title":"Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant","volume":"18","author":"Hamouda","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0080","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1016\/j.vaccine.2012.05.085","article-title":"Novel Th1-biased adjuvant, SPO1, enhances mucosal and systemic immunogenicity of vaccines administered intranasally in mice","volume":"30","author":"Yu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0085","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1016\/j.vaccine.2012.04.032","article-title":"Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration","volume":"30","author":"de Haan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0090","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1016\/j.vaccine.2012.09.007","article-title":"Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine","volume":"30","author":"Das","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0095","series-title":"Abstract for the fourth international conference on: modern vaccines adjuvants & delivery systems","article-title":"A nasal influenza vaccine with unique safety profile and robust immunogenic properties","author":"Hinkula","year":"2012"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0100","series-title":"Abstract presented at the seventh conference on global health and vaccination research: innovation for global health","article-title":"Immunotherapy of HIV-infected patients. Safety and immunogenicity of intranasal administration of Vacc-4x with Endocine as adjuvant","author":"Brekke","year":"2012"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0105","doi-asserted-by":"crossref","first-page":"e70527","DOI":"10.1371\/journal.pone.0070527","article-title":"N3OA and N3OASq; three mucosal adjuvants that enhance the immune response to nasal influenza vaccination","volume":"8","author":"Falkeborn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0110","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.1016\/j.vaccine.2010.07.001","article-title":"The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination","volume":"28","author":"Petersson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/laban1004-50","article-title":"The ferret: an animal model to study influenza virus","volume":"33","author":"Maher","year":"2004","journal-title":"Lab Anim (NY)"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1242\/dmm.007823","article-title":"The ferret as a model organism to study influenza A virus infection","volume":"4","author":"Belser","year":"2011","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0125","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2007.070248","article-title":"Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals","volume":"171","author":"van Riel","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/01902148009069646","article-title":"Ultrastructure of the nonciliated bronchiolar epithelial (Clara) cell of mammalian lung. III. A study of man with comparison of 15 mammalian species","volume":"1","author":"Plopper","year":"1980","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0135","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1125548","article-title":"H5N1 virus attachment to lower respiratory tract","volume":"312","author":"van Riel","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0140","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1099\/vir.0.032805-0","article-title":"Pulmonary pathology of pandemic influenza A\/H1N1 virus (2009)-infected ferrets upon longitudinal evaluation by computed tomography","volume":"92","author":"Veldhuis Kroeze","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0145","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1016\/j.vaccine.2012.10.008","article-title":"Consecutive CT in vivo lung imaging as quantitative parameter of influenza vaccine efficacy in the ferret model","volume":"30","author":"Veldhuis Kroeze","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1177127","article-title":"Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets","volume":"325","author":"Munster","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0155","series-title":"Advanced laboratory techniques for influenza diagnosis: procedural guide","first-page":"25","article-title":"Hemagglutination inhibition test","author":"Palmer","year":"1975"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0160","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/JCM.12.3.426-432.1980","article-title":"Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement","volume":"12","author":"Frank","year":"1980","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0165","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-0934(98)00071-8","article-title":"Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro","volume":"74","author":"Rimmelzwaan","year":"1998","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0175","doi-asserted-by":"crossref","first-page":"e42343","DOI":"10.1371\/journal.pone.0042343","article-title":"Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets","volume":"7","author":"van den Brand","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0180","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1086\/651132","article-title":"Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus","volume":"201","author":"van den Brand","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0185","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/infdis\/jiq144","article-title":"Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets","volume":"203","author":"Chen","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0190","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1016\/j.vaccine.2011.09.049","article-title":"Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets","volume":"29","author":"Stittelaar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0195","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.vaccine.2010.12.125","article-title":"Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naive ferrets","volume":"29","author":"Baras","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0200","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.vaccine.2010.12.128","article-title":"Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets","volume":"29","author":"Baras","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0205","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1128\/JVI.00674-12","article-title":"Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets","volume":"86","author":"Pearce","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1128\/CVI.00396-10","article-title":"Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands","volume":"18","author":"Bodewes","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0215","first-page":"12","article-title":"Development of adenoids: a study by measurement with MR images","volume":"15","author":"Jaw","year":"1999","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0220","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0002-9440(10)64841-9","article-title":"Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils","volume":"157","author":"Boyaka","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0225","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.168.4.1796","article-title":"Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses","volume":"168","author":"Zuercher","year":"2002","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2014.03.061_bib0230","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.ijporl.2003.08.018","article-title":"Immunology of tonsils and adenoids: everything the ENT surgeon needs to know","volume":"67","author":"Brandtzaeg","year":"2003","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0235","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2334-10-168","article-title":"Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children","volume":"10","author":"Usonis","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0240","unstructured":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)\u2014United States, 2012\u201313 influenza season. MMWR Morb Mortal Wkly Rep 2012;61:613-618."},{"key":"10.1016\/j.vaccine.2014.03.061_bib0245","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00431-005-0040-9","article-title":"Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts","volume":"165","author":"Heikkinen","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0250","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3201\/eid1004.030398","article-title":"Pediatric influenza prevention and control","volume":"10","author":"Principi","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2014.03.061_bib0255","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1469-0691.2012.03942.x","article-title":"Preventing influenza in younger children","volume":"18","author":"Esposito","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0260","first-page":"69","article-title":"How to better inform the decision making about universal influenza vaccination in children","volume":"7","author":"Yin","year":"2012","journal-title":"J Ped Infect Dis"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0265","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1081\/DDC-100101304","article-title":"Monoolein: a review of the pharmaceutical applications","volume":"26","author":"Ganem-Quintanar","year":"2000","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0270","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/jn\/127.3.488","article-title":"Endogenous synthesis cannot compensate for absence of dietary oleic acid in rats","volume":"127","author":"Bourre","year":"1997","journal-title":"J Nutr"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0021-9258(18)71927-3","article-title":"The isolation and properties of some naturally occuring octadecenoic (oleic) acids","volume":"154","author":"Millican","year":"1944","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0280","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.1016\/j.vaccine.2012.10.007","article-title":"Adjuvants in influenza vaccines","volume":"30","author":"Tetsutani","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0285","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1056\/NEJMoa073121","article-title":"A clinical trial of a whole-virus H5N1 vaccine derived from cell culture","volume":"358","author":"Ehrlich","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0290","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.03.061_bib0295","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1016\/j.vaccine.2012.04.109","article-title":"Mucosal IgA responses in influenza virus infections; thoughts for vaccine design","volume":"30","author":"van Riet","year":"2012","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T06:15:10Z","timestamp":1648707310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14004307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":59,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14004307"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasally administered Endocine\u2122 formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}